CAPS - Capstone Therapeutics Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.45M
Enterprise Value 32.89M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.27

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.32%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-1.54M
Diluted EPS (ttm)-0.035
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.72M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)2.16M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.34
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-1.56M
Levered Free Cash Flow (ttm)-963.75k

Trading Information

Stock Price History

Beta 2.08
52-Week Change 3-50.00%
S&P500 52-Week Change 322.42%
52 Week High 30.110
52 Week Low 30.040
50-Day Moving Average 30.050
200-Day Moving Average 30.061

Share Statistics

Avg Vol (3 month) 329.97k
Avg Vol (10 day) 34.98k
Shares Outstanding 554.39M
Float 28.92M
% Held by Insiders 150.61%
% Held by Institutions 14.99%
Shares Short 326.56k
Short Ratio 30.25
Short % of Float 30.08%
Shares Short (prior month) 333.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Jun 26, 1996